See more : Norcod AS (NCOD.OL) Income Statement Analysis – Financial Results
Complete financial analysis of Choom Holdings Inc. (CHOO.CN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Choom Holdings Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Pangaea Oncology, S.A. (PANG.MC) Income Statement Analysis – Financial Results
- Helvetia Holding AG (HELNF) Income Statement Analysis – Financial Results
- Tian An Australia Limited (TIA.AX) Income Statement Analysis – Financial Results
- Mind Medicine (MindMed) Inc. (MMDCF) Income Statement Analysis – Financial Results
- Rocky Mountain Ayre, Inc. (RMTN) Income Statement Analysis – Financial Results
Choom Holdings Inc. (CHOO.CN)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://choomholdings.ca
About Choom Holdings Inc.
Choom Holdings Inc., together with its subsidiaries, engages in the retail of cannabis. It sells cannabis products and accessories. The company's cannabis accessories include rolling papers, holders, pipes, water pipes, bongs, vaporizers, and other things used to consume cannabis. As of June 30, 2021, it operated through 17 retail stores in Canada. The company was formerly known as Standard Graphite Corporation and changed its name to Choom Holdings Inc. in November 2017. Choom Holdings Inc. was incorporated in 2006 and is headquartered in Vancouver, Canada.
| Metric | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 22.05M | 7.95M | 268.32K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 13.91M | 5.31M | 156.99K | 27.27K | 0.00 | 0.00 | 0.00 | 117.59 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 8.14M | 2.64M | 111.34K | -27.27K | 0.00 | 0.00 | 0.00 | -117.59 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 36.90% | 33.17% | 41.49% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 165.68 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 345.15K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 8.45M | 9.13M | 11.24M | 3.66K | 262.18 | 318.01 | 296.95 | 374.71 | 665.15 | 1.55K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 297.36K | 675.47K | 1.48K | 1.61M | 49.19 | 61.00 | 72.00 | 85.73 | 449.68 | 185.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 8.75M | 9.80M | 11.24M | 5.34K | 311.37 | 379.01 | 368.95 | 460.43 | 1.11K | 1.74K | 408.67K | 135.75K | 215.57K | 120.23K | 32.08K |
| Other Expenses | -43.49K | 623.46K | 238.20K | -1.38M | 2.90K | 531.00 | 3.43K | 121.25K | 118.10K | 137.09K | 3.14K | 227.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 12.68M | 11.58M | 11.88M | 6.15K | 686.48 | 632.88 | 1.05K | 1.30K | 1.56K | 1.88K | 411.81K | 135.98K | 215.57K | 120.23K | 32.08K |
| Cost & Expenses | 26.59M | 16.89M | 12.04M | 6.15K | 686.48 | 632.88 | 1.05K | 1.41K | 1.56K | 1.88K | 411.81K | 135.98K | 215.57K | 120.23K | 32.08K |
| Interest Income | 26.93K | 295.25K | 153.32K | 3.16K | 48.00 | 326.00 | 1.66K | 2.78K | 4.04K | 2.41K | 0.00 | 0.00 | 5.11K | 6.50K | 2.00K |
| Interest Expense | 5.42M | 3.84M | 1.55M | 3.16K | 48.00 | 326.00 | 1.66K | 2.78K | 4.04K | 2.41K | 5.09K | -488.00 | 5.11K | 0.00 | 0.00 |
| Depreciation & Amortization | 3.91M | 1.71M | 10.21K | 27.27K | 360.00 | 253.87 | 681.37 | 836.67 | 415.00 | 144.22 | 3.14K | 227.00 | 10.22K | 6.50K | 2.00K |
| EBITDA | -648.55K | -6.26M | -11.37M | -5.51K | -311.37 | -379.01 | -368.95 | -578.02 | -1.11K | -1.74K | -398.48K | -136.73K | -205.35K | -113.73K | -30.08K |
| EBITDA Ratio | -2.94% | -78.79% | -4,237.99% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -4.88M | -9.16K | -11.73K | -5.51K | -736.23 | -632.88 | -1.05K | -1.41K | -1.53K | -1.88K | -411.81K | -135.98K | -215.57K | -120.23K | -32.08K |
| Operating Income Ratio | -22.13% | -0.12% | -4.37% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -15.25M | -11.03K | -1.86K | -636.34 | 49.80 | 0.33 | 0.26 | 2.64 | -27.93 | 1.93 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -20.13M | -20.41M | -13.59M | -6.14K | -686.43 | -632.56 | -1.05K | -1.41K | -1.56K | -1.88K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | -91.29% | -256.85% | -5,066.46% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 86.43K | -166.52K | -2.16M | -346.41K | -374.66K | -252.69K | -676.02K | -827.59K | -435.23K | -136.66K | 5.09K | -488.00 | -5.11K | -6.50K | -2.00K |
| Net Income | -21.62M | -20.35M | -101.15M | -6.14K | -686.43 | -632.56 | -1.05K | -1.41K | -1.56K | -1.88K | -406.71K | -136.47K | -210.46K | -113.73K | -30.08K |
| Net Income Ratio | -98.07% | -256.09% | -37,698.05% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.07 | -0.10 | -0.55 | -0.07 | -0.01 | -0.01 | -0.02 | -0.04 | -0.05 | -0.10 | -0.03 | -0.01 | -0.06 | -0.01 | 0.00 |
| EPS Diluted | -0.07 | -0.10 | -0.55 | -0.07 | -0.01 | -0.01 | -0.02 | -0.04 | -0.05 | -0.10 | -0.03 | -0.01 | -0.06 | -0.01 | 0.00 |
| Weighted Avg Shares Out | 292.87M | 205.12M | 183.91M | 88.42K | 56.69K | 46.27K | 43.54K | 36.52K | 30.90K | 18.71K | 14.75M | 10.82M | 3.32M | 9.03M | 6.50M |
| Weighted Avg Shares Out (Dil) | 292.87M | 205.12M | 183.91M | 88.42K | 56.69K | 46.27K | 43.54K | 36.52K | 30.90K | 18.71K | 14.75M | 10.82M | 3.32M | 10.32M | 6.50M |
Source: https://incomestatements.info
Category: Stock Reports